People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

Mass General Brigham researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications, such as semaglutide or tir ...

The growing prevalence of diabetes, primarily due to obesity, aging populations, and sedentary lifestyles, is a key factor ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

Five scientists won this year’s Breakthrough Prize in Life Sciences for their work on GLP-1 and the development of drugs for ...

Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

Keyshawn Johnson, appearing on Fox’s Speak, shed light on just how far-reaching the “Prime Effect” really is, touching not only on Colorado’s football resurgence but also on the broader ...

Type 2 diabetes mellitus (T2DM ... 4 (DPP-4), the enzyme responsible for incretin degradation, leading to sustained incretin activity and improved insulinotropic effects. Influence on PYY and CCK ...

Beyond the excitement, questions remain about its safety, long-term effects ... The drug also carries a risk of low blood sugar when combined with insulin or sulfonylureas. GIP and GLP-1 drugs work by ...

Type 2 diabetes mellitus (T2DM ... leading to sustained incretin activity and improved insulinotropic effects. Flavonoids regulate satiety-related gut hormones, such as PYY and CCK, which ...

Type 2 diabetes mellitus (T2DM ... leading to sustained incretin activity and improved insulinotropic effects. Influence on PYY and CCK Flavonoids regulate satiety-related gut hormones, such ...